Glycoconjugates and neuroimmunological diseases.

Area of Science:

• Neuroimmunology
• Peripheral Nervous System (PNS) Disorders
• Glycobiology

Background:

• Neuroimmunological diseases result from autoimmune responses targeting diverse nervous system antigens.
• Peripheral neuropathies are a subset of PNS disorders where autoantibodies attack nerve glycan structures, particularly gangliosides.
• Guillain-Barré syndrome (GBS) is a key example, often preceded by infections like Campylobacter jejuni enteritis.

Purpose of the Study:

• To describe the immunological, pathological, and clinical features of autoimmune peripheral neuropathies.
• To explore the role of glycobiology in understanding these neuroimmunological disorders.
• To detail specific autoantibody targets, including gangliosides and other nerve glycans.

Main Methods:

• Review of immunological, pathological, and clinical data on neuroimmunological diseases.
• Analysis of autoantibody targets in peripheral neuropathies, focusing on glycan structures.
• Integration of glycobiology principles to explain disease mechanisms.

Main Results:

• Autoantibodies against nerve glycans, such as gangliosides, are implicated in peripheral nerve injury.
• Specific glycan targets include sulphated glucuronic acid epitopes, disialylated gangliosides (GD1b, GD3), and GM1 ganglioside.
• Chronic autoimmune neuropathies are associated with IgM antibodies targeting these nerve glycans.

Conclusions:

• Autoimmune attacks on nerve glycans are a significant mechanism in peripheral neuropathies.
• Understanding the glycobiology of peripheral nerve antigens is crucial for diagnosing and treating these conditions.
• The study highlights the link between infections, autoantibody production, and the development of GBS and chronic autoimmune neuropathies.